angiotensin ii has been researched along with puerarin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HF; Li, SM; Liu, B | 1 |
| Chen, G; He, QY; Pan, SF; Pan, SQ; Shen, C; Zhang, XM | 1 |
| Chong, S; Gang, C; Lihong, L; Qiang, C; Shifen, P; Xiangli, C | 1 |
| Li, X; Li, Y; Lin, Y; Wang, A; Wang, H; Zhou, H; Zhou, MS | 1 |
| Chen, B; Chen, Z; Fu, C; Guo, R; Jin, X; Liu, X; Wang, F; Wang, L; Zhang, Y; Zheng, H | 1 |
| Chen, L; Chen, M; Cheng, H; Dong, M; Jiang, C; Jiang, R; Li, M; Liu, Q; Xu, X; Zhou, K | 1 |
| Cai, DF; Cai, SA; Chen, MS; Chen, XH; Cheng, CF; Hou, N; Huang, Y; Li, AQ; Li, LR; Liu, SM; Liu, XW; Luo, CF; Qiu, XX; Xie, JX; Yuan, WC; Zhao, GJ | 1 |
1 trial(s) available for angiotensin ii and puerarin
| Article | Year |
|---|---|
[Effect of puerarin on plasma endothelin, renin activity and angiotensin II in patients with acute myocardial infarction].
Topics: Aged; Angiotensin II; Endothelins; Female; Humans; Isoflavones; Male; Middle Aged; Myocardial Infarction; Renin; Renin-Angiotensin System; Vasodilator Agents | 1997 |
6 other study(ies) available for angiotensin ii and puerarin
| Article | Year |
|---|---|
Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.
Topics: Administration, Oral; Angiotensin II; Animals; Antioxidants; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hypertrophy, Left Ventricular; Isoflavones; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; NF-kappa B; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Reactive Oxygen Species; Signal Transduction; Tetrazoles; Ultrasonography; Valine; Valsartan; Ventricular Remodeling | 2014 |
Puerarin Suppresses Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting NADPH Oxidase Activation and Oxidative Stress-Triggered AP-1 Signaling Pathways.
Topics: Angiotensin II; Animals; Cardiomegaly; Dose-Response Relationship, Drug; Enzyme Activation; Isoflavones; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Structure-Activity Relationship; Transcription Factor AP-1 | 2015 |
Puerarin protects against endothelial dysfunction and end-organ damage in Ang II-induced hypertension.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Blood Pressure; China; Endothelium, Vascular; Heart Ventricles; Hypertension; Isoflavones; Male; Membrane Glycoproteins; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide Synthase Type III; Organ Size; Oxidative Stress; Phosphorylation; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Tunica Media; Vascular Cell Adhesion Molecule-1; Vasodilation; Vasodilator Agents | 2017 |
Puerarin protects endothelial progenitor cells from damage of angiotensin II via activation of ERK1/2‑Nrf2 signaling pathway.
Topics: Angiotensin II; beta-Galactosidase; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Endothelial Progenitor Cells; Gene Expression Regulation; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Isoflavones; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-E2-Related Factor 2; Primary Cell Culture; Reactive Oxygen Species; Signal Transduction; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Vasodilator Agents | 2018 |
Puerarin Decreases Collagen Secretion in AngII-Induced Atrial Fibroblasts Through Inhibiting Autophagy Via the JNK-Akt-mTOR Signaling Pathway.
Topics: Angiotensin II; Animals; Autophagy; Cardiovascular Agents; Cells, Cultured; Collagen; Dose-Response Relationship, Drug; Fibroblasts; Fibrosis; Heart Atria; Isoflavones; JNK Mitogen-Activated Protein Kinases; Mice; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases | 2019 |
Puerarin ameliorated pressure overload-induced cardiac hypertrophy in ovariectomized rats through activation of the PPARα/PGC-1 pathway.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Cardiomegaly; Cardiotonic Agents; Constriction, Pathologic; Energy Metabolism; Female; Isoflavones; Myocardium; Myocytes, Cardiac; Ovariectomy; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR alpha; Rats, Sprague-Dawley; Signal Transduction | 2021 |